Home » International Regulatory » Europe » REACH
REACH
REACH (Registration, Evaluation, Authorization and restriction of Chemicals) (Regulation (EC) No 1907/2006) entered into force on June 1, 2007. The Regulation will have a significant impact on manufacturers and exporters to the European Union (EU). REACH Timetable
Some chemical products, such as pharmaceuticals, biocides and pesticides are partially exempt but the companies involved must still assess their obligations under REACH.
The key stages of REACH involve:
- Pre-registration: of ‘phase-in' (existing) substances (to be completed by December 2008)
- Registration: submission of a dossier by specific deadlines depending on annual tonnage and on certain hazardous properties of the individual substances
- Evaluation: dossier review by the European Chemicals Agency and the Member States Competent Authorities
- Authorization: authorization of substances of concern (such as CMRs, PBTs, vPvBs and other substances of equivalent concern [i] ) by specific uses, under specific conditions, for specific time periods
- Restriction: regulation of substances – covering manufacturing, marketing and/or conditions of use.
Consortia based on Substance Information Exchange Forum (SIEF) will play a key role in the REACH process from registration to authorization or restriction. Amongst their roles, successful consortia will facilitate exchanges of information, avoid duplication of studies and facilitate agreements on classification and labeling. Based on our extensive experience with consortia in other regulated chemical sectors TSGE and TSG are well placed to help establish and manage consortia, represent companies, and provide independent advice.
For scientific issues under REACH, o
- Design and implementation of technical strategies for supporting substances through REACH
- Assessment of chemical inventories for data compliance (upstream and downstream companies)
- Evaluation of existing data, devise and commissioning new studies and programs
- Running seminars on REACH, its implications and implementation
- Providing advice and strategy to address data deficiencies (from QSARs, read-across
[ii]
, waivers, public domain data, data sharing etc).
TSG's REACH Services
TSG and our European affiliate, TSGE, are able to offer assistance and consultancy in all aspects of the requirements of REACH. We offer REACH-based consultancy services tailored to the particular requirements of companies and examples of this are listed below.
General advice on the obligations and impact that REACH imposes on businesses, which measures should be undertaken and when:
- Early stage training
- Advice on the obligations of companies
- Seeking potential consortium partners [iii]
- Establishing consortia; avoiding pitfalls
- Representation in the early stages of consortium establishment
- Establishing TSGE as an ‘only representative' or a ‘third party representative' [iv]
- Coordination of establishing an EU enterprise
- Establishing an inventory of all substances, substances in preparations and in articles
- Listing possible pre-registration candidates
- Reviewing and updating Safety Data Sheets (SDSs)
- Establishing known properties (physical, environmental, toxicological)
- Identifying the potential classification of substances, within the scope of REACH and assessing their properties (CMR, PBT, vPvB)
- Designing and implementing strategies for these substances under REACH
- Contacting suppliers and customers to determine their REACH readiness
- Contacting customers to determine their product uses
- Contacting suppliers to confirm your product uses
- Collating and establishing the value of data (public domain, proprietary)
- Evaluating quality and relevance of existing data, development of strategies to support existing data
- Determining potential for data waivers, undertaking of QSAR, read-across strategies as a surrogate for new studies
- Establishing strategies for use and exposure scenarios
- Pre-registration preparation and submission
- Designing, commissioning and monitoring scientific testing
- Evaluating and developing supporting strategies for data packages for completeness, quality and relevance
- Registration dossier preparation and submission
- Chemical safety assessments and preparation of the CSR and SDS
- Preparation of testing proposals
- Negotiation with CA or with ECA consortia formation and representation
- Consortia formation and representation
Robert R. Stewart ▪ (202) 828-8963 ▪ RStewart@TSGUSA.com
i CMR (Carcinogenic, Mutagenic and Reproductive), PBT (Persistent, Bioaccumulative and Toxic def) and vPvB (very Persistent and very Bioaccumulative)
ii QSAR: Quantitative Structure-Activity Relationships. The use of computational modeling methods to predicts unknown properties of a substance from known structural parameters. Read across: using the known properties of a chemical or group of chemicals to predict the properties of another related chemical
- Home
- U.S. Federal Regulatory
- U.S. State Regulatory
- International Regulatory
- Science
- Compliance & Litigation Support
Affiliates: